Geoffroy Liegeon

12PUBLICATIONS
56CO-AUTHORS
Aboriginal and Torres Strait Islander medicine and treatmentsRespiratory diseasesInformation systems user experience design and developmentMedical bacteriologyPreventative health care
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (12)

|Sep 23, 2026
Satisfaction and Treatment Burden Among Early Adopters of Long-Acting Injectable Cabotegravir-Rilpivirine With and Without Viremia in Three US Ryan White Clinics.

|May 25, 2026
Renal Outcomes in People With HIV-1 and Renal Impairment Treated With Bictegravir/Emtricitabine/Tenofovir Alafenamide: Integrated Analysis From 9 Phase 3/3b Clinical Trials.

|Mar 14, 2026
Safety and Tolerability of Oral Islatravir Once Monthly as Pre-exposure Prophylaxis in Cisgender Men and Transgender Women Who Have an Elevated Likelihood of HIV-1 Exposure: Results From the IMPOWER-24 Randomized Phase 3 Study.

Raphael J Landovitz, Yvett Pinedo, Federico Hinestrosa

|Nov 09, 2025
Antimicrobial-Resistant Neisseria gonorrhoeae Infections in Men Using Doxycycline Postexposure Prophylaxis: A Substudy of the ANRS 174 DOXYVAC Trial.

Béatrice Bercot, Lambert Assoumou, François Caméléna

|Oct 15, 2025
A Survey Study of Concerns and Attitudes Toward Doxycycline Postexposure Prophylaxis Among Bathhouse-Affiliated Individuals in the United States and Canada.

Michael Wasz, Aniruddha Hazra, Laura Rusie

|Sep 22, 2025
Eligibility and factors associated with long-acting injectable cabotegravir-rilpivirine initiation in an urban academic HIV clinic.

Geoffroy Liegeon, Eleanor Friedman, Christopher Kaperak

Pageof 2

Frequent Collaborators

3 joint publications

Aniruddha Hazra

3 joint publications

Katerina A Christopoulos

2 joint publications

Samantha A Devlin

2 joint publications

Laurence Slama